2023年3月30日

該投資將使公司能夠開發新功能並擴大deepcOS®的商業化，deepcOS®是其專有的操作係統，為放射學工作流程中的人工智能集成提供動力。Sofinnova Partners的合夥人Simon Turner加入deepc的董事會。一家數字醫學先驅，使醫療係統能夠靈活地采用和集成第三方人工智能(AI)技術到現有的工作流程中，並最終改善患者的治療結果。該公司今天宣布，已獲得由Sofinnova Partners領投的1200萬美元a輪融資，Sofinnova Partners是歐洲領先的生命科學風險投資公司，專注於醫療保健和可持續性。所得收益將用於推動deepcOS®AI操作係統的商業化，並進一步開發簡化的服務，以改善放射科醫生的用戶體驗。貝塔斯曼投資公司(Bertelsmann Investments)和現有投資者Winning Mindset Ventures也參與了本輪融資。該公司的核心技術deepcOS®是一個雲原生、供應商中立的平台，可與現有的放射學工作流程無縫集成。它為經過批準的第三方人工智能供應商提供了一種有效的方法來商業化他們的解決方案，同時為醫院和診所提供安全的一站式服務，以滿足他們的人工智能輔助放射學需求。deepc聯合創始人兼首席執行官Franz Pfister博士表示:“在deepc，我們相信人工智能有能力徹底改變我們的醫療保健方式。我們的人工智能平台deepcOS是放射學的遊戲規則改變者，允許更快、更準確的診斷，並最終改善患者的結果。我們非常高興地歡迎Sofinnova Partners和貝塔斯曼投資公司的加入。他們在醫療生態係統中的廣泛網絡將推動deepc向前發展。” The proceeds will expand deepc’s geographic coverage and develop additional features within deepcOS®. Radiology teams will benefit as new AI-assisted options are seamlessly integrated into their workflows. At the same time, AI software vendors will get low-friction access to a large number of potential customers. "Our investment in deepc underscores our conviction that Digital Medicine holds enormous promise and that enabling technologies will be at the forefront of the digital revolution in healthcare, precisely the focus of our Digital Medicine investment strategy," said Simon Turner, Partner at Sofinnova Partners. “deepcOS enables wide adoption of AI into a major part of the patient journey. The team has demonstrated the benefit that they can provide to healthcare professionals and patients.” Company contact: sofinnova@optimumcomms.com About deepc Driven by a desire to ensure precise diagnostics for all patients, deepc is on a mission to cut through the challenges of a crowded AI market and provide radiology teams with seamless access to an array of the best regulator-approved AI diagnostic tools. Its growing team of more than 40 employees with 20 different nationalities working in seven cities is dedicated to improving the AI user experience for radiologists while easing market access for AI software vendors. For more information, please visit: www.deepc.ai About Sofinnova Partners Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London, and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical, and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future. Founded in 1972, Sofinnova Partners is a deeply established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €2.5 billion under management. For more information, please visit: www.sofinnovapartners.com About Bertelsmann Investments Bertelsmann Investments (BI), bundles Bertelsmann's growth initiatives through Bertelsmann Next and VC Investment businesses including Bertelsmann Asia Investments (BAI), Bertelsmann India Investments (BII), and Bertelsmann Digital Media Investments (BDMI). Bertelsmann's global venture capital arm currently comprises 300 active investments while Bertelsmann Next is investing to create transformational businesses in Digital Health, Employability and other sectors such as App conomy. For more information, please visit: www.bertelsmann-investments.com